3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid

C29H27F3N4O6S — CID 146372168

IUPAC3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid
SMILESCc1ccc(C(CC(=O)O)c2ccn3c(C(F)(F)F)nnc3c2C)cc1CN1CC2(COC2)Oc2ccccc2S1(=O)=O
InChIInChI=1S/C29H27F3N4O6S/c1-17-7-8-19(22(12-25(37)38)21-9-10-36-26(18(21)2)33-34-27(36)29(30,31)32)11-20(17)13-35-14-28(15-41-16-28)42-23-5-3-4-6-24(23)43(35,39)40/h3-11,22H,12-16H2,1-2H3,(H,37,38)
InChIKeyBWBKVCYHPGTSEI-UHFFFAOYSA-N
MW616.62 g/mol
LogP4.32
Rot. Bonds6

About 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid

3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid (PubChem CID 146372168) has the molecular formula C29H27F3N4O6S and a molecular weight of 616.62 g/mol. Its IUPAC name is 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid.

Molecular Properties

Compound Name3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid
PubChem CID146372168
Molecular FormulaC29H27F3N4O6S
Molecular Weight616.62 g/mol
Exact Mass616.16
IUPAC Name3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid
SMILESCc1ccc(C(CC(=O)O)c2ccn3c(C(F)(F)F)nnc3c2C)cc1CN1CC2(COC2)Oc2ccccc2S1(=O)=O
InChIInChI=1S/C29H27F3N4O6S/c1-17-7-8-19(22(12-25(37)38)21-9-10-36-26(18(21)2)33-34-27(36)29(30,31)32)11-20(17)13-35-14-28(15-41-16-28)42-23-5-3-4-6-24(23)43(35,39)40/h3-11,22H,12-16H2,1-2H3,(H,37,38)
InChIKeyBWBKVCYHPGTSEI-UHFFFAOYSA-N
XLogP4.32
TPSA123.33 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms43
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500616.62
LogP ≤ 54.32
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid?
The IUPAC name of 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid (CID 146372168) is 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid.
What is the SMILES notation for 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid?
The canonical SMILES for 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid is Cc1ccc(C(CC(=O)O)c2ccn3c(C(F)(F)F)nnc3c2C)cc1CN1CC2(COC2)Oc2ccccc2S1(=O)=O.
What is the InChIKey of 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid?
The InChIKey is BWBKVCYHPGTSEI-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H27F3N4O6S/c1-17-7-8-19(22(12-25(37)38)21-9-10-36-26(18(21)2)33-34-27(36)29(30,31)32)11-20(17)13-35-14-28(15-41-16-28)42-23-5-3-4-6-24(23)43(35,39)40/h3-11,22H,12-16H2,1-2H3,(H,37,38).
What are the key properties of 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid?
3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid has a molecular weight of 616.62 g/mol, XLogP of 4.32, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-[(1,1-dioxospiro[3H-5,1λ6,2-benzoxathiazepine-4,3'-oxetane]-2-yl)methyl]-4-methylphenyl]-3-[8-methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]propanoic acid is sourced from PubChem (CID 146372168), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).